{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:46:24Z","timestamp":1789238784515,"version":"build-2803163510"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran","award":["1403-1121"],"award-info":[{"award-number":["1403-1121"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antonie van Leeuwenhoek"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10482-025-02217-2","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:21:12Z","timestamp":1765988472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of gut microbiota in breast cancer: biomarker identification and therapeutic applications"],"prefix":"10.1007","volume":"119","author":[{"given":"Melika","family":"Abrishami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Sabouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshte","family":"Joneidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Haghshenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazaleh","family":"Khalili-Tanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"6","key":"2217_CR1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41430-020-00847-5","volume":"75","author":"C Abe","year":"2021","unstructured":"Abe C, Imai T, Sezaki A, Miyamoto K, Kawase F, Shirai Y et al (2021) A longitudinal association between the traditional Japanese diet score and incidence and mortality of breast cancer\u2014an ecological study. Eur J Clin Nutr 75(6):929\u2013936","journal-title":"Eur J Clin Nutr"},{"issue":"23","key":"2217_CR2","volume":"1","author":"DH Aboubaker","year":"2025","unstructured":"Aboubaker DH (2025) Lactobacillus in cancer therapy: a critical mechanistic review. J Agric Food Res 1(23):102256","journal-title":"J Agric Food Res"},{"issue":"1","key":"2217_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01679-24","volume":"16","author":"Y Alam","year":"2025","unstructured":"Alam Y, Hakopian S, de Ortiz Ora L, Tamburini I, Avelar-Barragan J, Jung S et al (2025) Variation in human gut microbiota impacts tamoxifen pharmacokinetics. Mbio 16(1):e01679-24","journal-title":"Mbio"},{"issue":"11","key":"2217_CR4","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/metabo11110758","volume":"11","author":"MM Al-Ansari","year":"2021","unstructured":"Al-Ansari MM, AlMalki RH, Dahabiyeh LA, Abdel Rahman AM (2021) Metabolomics-microbiome crosstalk in the breast cancer microenvironment. Metabolites 11(11):758","journal-title":"Metabolites"},{"key":"2217_CR5","doi-asserted-by":"crossref","unstructured":"Ali S, Mehboob A, Arshad M, Mammadova K, Ahmad MU (2025) Bacterial oncolytic therapy as a novel approach for cancer treatment in humans. Cancer Treat Res Commun, 43. https:\/\/pubmed.ncbi.nlm.nih.gov\/40088595\/","DOI":"10.1016\/j.ctarc.2025.100892"},{"key":"2217_CR6","first-page":"12","volume":"25","author":"D Alpuim Costa","year":"2021","unstructured":"Alpuim Costa D, Nobre JG, Batista MV, Ribeiro C, Calle C, Cortes A et al (2021) Human microbiota and breast cancer\u2014is there any relevant link?\u2014a literature review and new horizons toward personalised medicine. Front Microbiol 25:12","journal-title":"Front Microbiol"},{"issue":"1","key":"2217_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12094-024-03554-w","volume":"27","author":"A Amaro-da-Cruz","year":"2024","unstructured":"Amaro-da-Cruz A, Rubio-Tom\u00e1s T, \u00c1lvarez-Mercado AI (2024) Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy. Clin Transl Oncol 27(1):15\u201341","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"2217_CR8","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41598-023-32227-x","volume":"13","author":"J An","year":"2023","unstructured":"An J, Yang J, Kwon H, Lim W, Kim YK, Moon BI (2023) Prediction of breast cancer using blood microbiome and identification of foods for breast cancer prevention. Sci Rep 13(1):5110","journal-title":"Sci Rep"},{"issue":"1","key":"2217_CR9","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac177","volume":"164","author":"AA Arnone","year":"2023","unstructured":"Arnone AA, Cook KL (2023) Gut and breast microbiota as endocrine regulators of hormone receptor-positive breast cancer risk and therapy response. Endocrinology 164(1):bqac177. https:\/\/doi.org\/10.1210\/endocr\/bqac177","journal-title":"Endocrinology"},{"issue":"5_Supplement","key":"2217_CR10","doi-asserted-by":"publisher","first-page":"P1-02-05","DOI":"10.1158\/1538-7445.SABCS22-P1-02-05","volume":"83","author":"A Arnone","year":"2023","unstructured":"Arnone A, Wilson AS, Chiba A, Kerr B, Soto-Pantoja DR, Thomas A et al (2023) Abstract P1\u201302\u201305: Endocrine-targeted therapies modify the gut microbiome affecting responsiveness in ER+ breast cancer. Cancer Res 83(5_Supplement):P1-02-05-P1-02-5","journal-title":"Cancer Res"},{"issue":"9","key":"2217_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1158\/1940-6207.CAPR-24-0055","volume":"17","author":"AA Arnone","year":"2024","unstructured":"Arnone AA, Wilson AS, Soto-Pantoja DR, Cook KL (2024) Diet modulates the gut microbiome, metabolism, and mammary gland inflammation to influence breast cancer risk. Canc Prevent Res 17(9):415\u2013428","journal-title":"Canc Prevent Res"},{"issue":"2","key":"2217_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s44321-024-00185-0","volume":"17","author":"AA Arnone","year":"2025","unstructured":"Arnone AA, Ansley K, Heeke AL, Howard-McNatt M, Cook KL (2025) Gut microbiota interact with breast cancer therapeutics to modulate efficacy. EMBO Mol Med 17(2):219-234\u2013234. https:\/\/doi.org\/10.1038\/s44321-024-00185-0","journal-title":"EMBO Mol Med"},{"key":"2217_CR13","doi-asserted-by":"crossref","unstructured":"Bai J, Eldridge R, Houser M, Martin M, Powell C, Sutton KS, et al. (2024) Multi-omics analysis of the gut microbiome and metabolites associated with the psychoneurological symptom cluster in children with cancer receiving chemotherapy. J Transl Med. 22(1):256 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10924342\/","DOI":"10.1186\/s12967-024-05066-1"},{"key":"2217_CR14","doi-asserted-by":"crossref","unstructured":"Balendra V, Rosenfeld R, Amoroso C, Castagnone C, Rossino MG, Garrone O, et al. (2025) Postbiotics as adjuvant therapy in cancer care. Nutrients. 16(15). https:\/\/pubmed.ncbi.nlm.nih.gov\/39125280\/","DOI":"10.3390\/nu16152400"},{"key":"2217_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109737","volume":"75","author":"JWO Ballard","year":"2020","unstructured":"Ballard JWO, Towarnicki SG (2020) Mitochondria, the gut microbiome and ROS. Cell Signal 75:109737","journal-title":"Cell Signal"},{"issue":"6529","key":"2217_CR16","first-page":"602","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L et al (2021) Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science (1979) 371(6529):602\u2013609","journal-title":"Science (1979)"},{"key":"2217_CR17","doi-asserted-by":"crossref","unstructured":"Bernardo G, Le Noci V, Di Modica M, Montanari E, Triulzi T, Pupa SM, et al. (2025) The Emerging Role of the Microbiota in Breast Cancer Progression. Cells, 12(15):1945. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10417285\/","DOI":"10.3390\/cells12151945"},{"key":"2217_CR18","doi-asserted-by":"crossref","unstructured":"Bodai BI, Nakata TE (2020) Breast cancer: lifestyle, the human gut microbiota\/microbiome, and survivorship. Perm J. 24(4). https:\/\/pubmed.ncbi.nlm.nih.gov\/32589577\/","DOI":"10.7812\/TPP\/19.129"},{"issue":"6","key":"2217_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1101\/gr.255620.119","volume":"30","author":"A Boot","year":"2020","unstructured":"Boot A, Ng AWT, Chong FT, Ho SC, Yu W, Tan DSW et al (2020) Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types. Genome Res 30(6):803\u2013813","journal-title":"Genome Res"},{"key":"2217_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coph.2019.04.017","volume":"49","author":"TJ Borody","year":"2019","unstructured":"Borody TJ, Eslick GD, Clancy RL (2019) Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer. Curr Opin Pharmacol 49:43\u201351","journal-title":"Curr Opin Pharmacol"},{"key":"2217_CR21","doi-asserted-by":"crossref","unstructured":"Bose C, Uczkowski NG, Sukla K, Raval N, Haque MM, Zhang Y, et al. (2025) Breast cancer and microbiome: a systematic review highlighting challenges for clinical translation. BMC Womens Health, 25(1):416 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12398099\/","DOI":"10.1186\/s12905-025-03843-8"},{"issue":"4","key":"2217_CR22","first-page":"374","volume":"2","author":"E Bruce","year":"2021","unstructured":"Bruce E, Makaranka S, Urquhart G, Elsberger B (2021) Does the gut microbiome environment influence response to systemic breast cancer treatment? Explor Target Antitumor Ther 2(4):374","journal-title":"Explor Target Antitumor Ther"},{"key":"2217_CR23","doi-asserted-by":"crossref","unstructured":"Budu O, Mioc A, Soica C, Caruntu F, Milan A, Oprean C, et al. (2024) Lactiplantibacillus plantarum induces apoptosis in melanoma and breast cancer cells. Microorganisms, 12(1):182. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10819835\/","DOI":"10.3390\/microorganisms12010182"},{"key":"2217_CR24","doi-asserted-by":"crossref","unstructured":"Byrd DA, Vogtmann E, Wu Z, Han Y, Wan Y, Clegg-Lamptey JN, et al. (2021) Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study. Int J Cancer. 148(11):2712\u20132723. https:\/\/pubmed.ncbi.nlm.nih.gov\/33460452\/","DOI":"10.1002\/ijc.33473"},{"key":"2217_CR25","unstructured":"Chukwunwejim CR, Okoye CS, Ekpunobi NF, Oghonyon EI, Obidi N, Agu KC (2025) Gut microbiome dynamics and their emerging role in breast and colorectal cancer: implications for diagnosis and therapy. 2025 Aug 7 [cited 2025 Nov 11]; https:\/\/europepmc.org\/article\/PPR\/PPR1065910"},{"key":"2217_CR26","doi-asserted-by":"crossref","unstructured":"Chan AA, Bashir M, Rivas MN, Duvall K, Sieling PA, Pieber TR, et al. (2016) Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors. Sci Reports, 6(1):1\u201311. https:\/\/www.nature.com\/articles\/srep28061","DOI":"10.1038\/srep28061"},{"issue":"11","key":"2217_CR27","first-page":"e1847","volume":"6","author":"SS Chapadgaonkar","year":"2023","unstructured":"Chapadgaonkar SS, Bajpai SS, Godbole MS (2023) Gut microbiome influences incidence and outcomes of breast cancer by regulating levels and activity of steroid hormones in women. Cancer Rep. 6(11):e1847","journal-title":"Cancer Rep."},{"issue":"1","key":"2217_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-025-02299-5","volume":"23","author":"K Chen","year":"2025","unstructured":"Chen K, Wang H, Yang Y, Tang C, Sun X, Zhou J et al (2025) Common mechanisms of Gut microbe-based strategies for the treatment of intestine-related diseases: based on multi-target interactions with the intestinal barrier. Cell Commun Signal 23(1):1\u201324. https:\/\/doi.org\/10.1186\/s12964-025-02299-5","journal-title":"Cell Commun Signal"},{"key":"2217_CR29","first-page":"1867","volume-title":"The role of gut microbiota in cancer treatment: Friend or foe?","author":"WY Cheng","year":"2020","unstructured":"Cheng WY, Wu CY, Yu J (2020) The role of gut microbiota in cancer treatment: Friend or foe?, vol 69. BMJ Publishing Group, London, pp 1867\u20131876"},{"key":"2217_CR30","doi-asserted-by":"crossref","unstructured":"Chia M, Pop M, Salzberg SL, Nagarajan N (2025) challenges and opportunities in analyzing cancer-associated microbiomes. Cancer Res. 85(19):3584. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12419811\/","DOI":"10.1158\/0008-5472.CAN-24-3629"},{"issue":"1","key":"2217_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1158\/1541-7786.MCR-19-0451","volume":"18","author":"A Chiba","year":"2020","unstructured":"Chiba A, Bawaneh A, Velazquez C, Clear KYJ, Wilson AS, Howard-McNatt M et al (2020) Neoadjuvant chemotherapy shifts breast tumor microbiota populations to regulate drug responsiveness and the development of metastasis. Mol Cancer Res 18(1):130\u2013139","journal-title":"Mol Cancer Res"},{"key":"2217_CR32","unstructured":"Chiba A, Bawaneh A, Velazquez C, Clear KYJ, Wilson AS, Howard-McNatt M, et al. (2019) Neoadjuvant chemotherapy shifts breast tumor microbiota populations to regulate drug responsiveness and the development of metastasis. Mol Cancer Res, 18(1):130. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9153322\/"},{"issue":"12_Supplement","key":"2217_CR33","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1158\/1538-7445.AM2022-5927","volume":"82","author":"B Chun","year":"2022","unstructured":"Chun B, Dindar DA, Stagaman K, Palma A, Dahl E, Kasschau K et al (2022) Abstract 5927: A comparison of the gut microbiome in the context of body mass index in patients with and without breast cancer. Cancer Res 82(12_Supplement):5927\u20135927","journal-title":"Cancer Res"},{"issue":"5_Supplement","key":"2217_CR34","doi-asserted-by":"publisher","first-page":"P1-04-02","DOI":"10.1158\/1538-7445.SABCS22-P1-04-02","volume":"83","author":"B Chun","year":"2023","unstructured":"Chun B, Goodyear S, Rice-Stitt T, Karstens L, Dahl E, Li A et al (2023) Abstract P1\u201304\u201302: Gut microbiome diversity correlates with tumor PD-L1 status in metastatic triple negative breast cancer (mTNBC): correlative analysis of gut microbiome and tumoral biomarkers. Cancer Res 83(5_Supplement):P1-04-02-P1-04-02","journal-title":"Cancer Res"},{"key":"2217_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100328","author":"C Danne","year":"2021","unstructured":"Danne C, Sokol H (2021) Butyrate, a new microbiota-dependent player in CD8+ T cells immunity and cancer therapy? Cell Rep Med. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100328","journal-title":"Cell Rep Med"},{"issue":"6529","key":"2217_CR36","first-page":"595","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM et al (2021) Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients. Science (1979) 371(6529):595\u2013602","journal-title":"Science (1979)"},{"issue":"4","key":"2217_CR37","doi-asserted-by":"publisher","first-page":"e00531-23","DOI":"10.1128\/msystems.00531-23","volume":"8","author":"T Desch\u00eanes","year":"2023","unstructured":"Desch\u00eanes T, Tohoundjona FWE, Plante PL, Di Marzo V, Raymond F (2023) Gene-based microbiome representation enhances host phenotype classification. mSystems 8(4):e00531-23","journal-title":"mSystems"},{"issue":"8","key":"2217_CR38","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1021\/acs.jmedchem.6b01243","volume":"60","author":"AT Dharmaraja","year":"2017","unstructured":"Dharmaraja AT (2017) Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria. J Med Chem 60(8):3221\u20133240","journal-title":"J Med Chem"},{"issue":"8","key":"2217_CR39","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1158\/0008-5472.CAN-20-1659","volume":"81","author":"M Di Modica","year":"2021","unstructured":"Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B et al (2021) Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer. Cancer Res 81(8):2195\u20132206","journal-title":"Cancer Res"},{"issue":"6","key":"2217_CR40","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ajpath.2021.02.020","volume":"191","author":"S Dieleman","year":"2021","unstructured":"Dieleman S, Aarnoutse R, Ziemons J, Kooreman L, Boleij A, Smidt M (2021) Exploring the potential of breast microbiota as biomarker for breast cancer and therapeutic response. Am J Pathol 191(6):968\u2013982","journal-title":"Am J Pathol"},{"key":"2217_CR41","doi-asserted-by":"crossref","unstructured":"Ervin SM, Li H, Lim L, Roberts LR, Liang X, Mani S, et al. (2019) Gut microbial \u03b2-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem. 294(49):18586\u201318599 https:\/\/pubmed.ncbi.nlm.nih.gov\/31636122\/","DOI":"10.1074\/jbc.RA119.010950"},{"key":"2217_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021110","author":"C Filippou","year":"2024","unstructured":"Filippou C, Themistocleous SC, Marangos G, Panayiotou Y, Fyrilla M, Kousparou CA et al (2024) Microbial therapy and breast cancer management: exploring mechanisms, clinical efficacy, and integration within the one health approach. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25021110","journal-title":"Int J Mol Sci"},{"issue":"26","key":"2217_CR43","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1038\/s41388-020-1341-1","volume":"39","author":"W Fong","year":"2020","unstructured":"Fong W, Li Q, Yu J (2020) Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene 39(26):4925\u20134943","journal-title":"Oncogene"},{"issue":"3","key":"2217_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/PPO.0000000000000048","volume":"20","author":"R Francescone","year":"2014","unstructured":"Francescone R, Hou V, Grivennikov SI (2014) Microbiome, inflammation, and cancer. Cancer J 20(3):181\u2013189","journal-title":"Cancer J"},{"key":"2217_CR45","doi-asserted-by":"crossref","unstructured":"Garg A, Ulucan-Karnak F, Shukla A, Garg S, Pandey P, Singh V, et al. (2025) Postbiotics: bioactive compounds and their effects. Cancer drug discovery and development [Internet]. Part 812:155\u201376. https:\/\/www.researchgate.net\/publication\/393257279_Postbiotics_Bioactive_Compounds_and_Their_Effects","DOI":"10.1007\/978-3-031-86065-2_7"},{"issue":"13_Supplement","key":"2217_CR46","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1158\/1538-7445.AM2021-1778","volume":"81","author":"Z Gerbec","year":"2021","unstructured":"Gerbec Z, Dedhar S, Finlay B (2021) Abstract 1778: Bacterial regulation of innate and adaptive tumor immunity in metastatic breast cancer. Cancer Res 81(13_Supplement):1778\u20131778","journal-title":"Cancer Res"},{"key":"2217_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127245","volume":"266","author":"R Ghotaslou","year":"2023","unstructured":"Ghotaslou R, Nabizadeh E, Memar MY, Law WMH, Ozma MA, Abdi M et al (2023) The metabolic, protective, and immune functions of Akkermansia muciniphila. Microbiol Res 266:127245","journal-title":"Microbiol Res"},{"key":"2217_CR48","doi-asserted-by":"crossref","unstructured":"Goedert JJ, Jones G, Hua X, Xu X, Yu G, Flores R, et al. (2015) Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. JNCI J National Cancer Institute. 107(8):djv147. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4554191\/","DOI":"10.1093\/jnci\/djv147"},{"key":"2217_CR49","first-page":"10","volume":"7","author":"X Guan","year":"2020","unstructured":"Guan X, Ma F, Sun X, Li C, Li L, Liang F et al (2020) Gut Microbiota profiling in patients with HER2-negative metastatic breast cancer receiving metronomic chemotherapy of capecitabine compared to those under conventional dosage. Front Oncol 7:10","journal-title":"Front Oncol"},{"issue":"14","key":"2217_CR50","first-page":"1499203","volume":"24","author":"H Guo","year":"2024","unstructured":"Guo H (2024) Interactions between the tumor microbiota and breast cancer. Front Cell Infect Microbiol 24(14):1499203","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"2217_CR51","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3892\/ol.2025.14956","volume":"29","author":"Y Guo","year":"2025","unstructured":"Guo Y, Dong W, Sun D, Zhao X, Huang Z, Liu C et al (2025) Bacterial metabolites: effects on the development of breast cancer and therapeutic efficacy. Oncol Lett 29(4):210","journal-title":"Oncol Lett"},{"issue":"4","key":"2217_CR52","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2183\/pjab.93.013","volume":"93","author":"M Hatakeyama","year":"2017","unstructured":"Hatakeyama M (2017) Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Japan Acad Ser B Phys Biol Sci 93(4):196\u2013219","journal-title":"Proc Japan Acad Ser B Phys Biol Sci"},{"issue":"1","key":"2217_CR53","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1002\/ctm2.250","volume":"11","author":"Y He","year":"2021","unstructured":"He Y, Liu QW, Liao HX, Xu WW (2021) Microbiota in cancer chemoradiotherapy resistance. Clin Transl Med 11(1):e250","journal-title":"Clin Transl Med"},{"issue":"6","key":"2217_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020702","volume":"6","author":"LM Hix","year":"2011","unstructured":"Hix LM, Shi YH, Brutkiewicz RR, Stein PL, Wang CR, Zhang M (2011) CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis. PLoS ONE 6(6):e20702","journal-title":"PLoS ONE"},{"issue":"10","key":"2217_CR55","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s12276-021-00686-9","volume":"53","author":"MF Hou","year":"2021","unstructured":"Hou MF, Ou-Yang F, Li CL, Chen FM, Chuang CH, Kan JY et al (2021) Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer. Exp Mol Med 53(10):1636\u20131646","journal-title":"Exp Mol Med"},{"issue":"8","key":"2217_CR56","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1021\/acs.chemrestox.0c00142","volume":"33","author":"YC Hsiao","year":"2020","unstructured":"Hsiao YC, Liu CW, Chi L, Yang Y, Lu K (2020) Effects of gut microbiome on carcinogenic DNA damage. Chem Res Toxicol 33(8):2130\u20132138","journal-title":"Chem Res Toxicol"},{"key":"2217_CR57","doi-asserted-by":"crossref","unstructured":"Hu S, Ding Q, Zhang W, Kang M, Ma J, Zhao L (2023) Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism. Gut Microbes. 15(1):2236749. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10416750\/","DOI":"10.1080\/19490976.2023.2236749"},{"key":"2217_CR58","doi-asserted-by":"crossref","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. 2013 Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science, 342(6161):967\u2013970. https:\/\/pubmed.ncbi.nlm.nih.gov\/24264989\/","DOI":"10.1126\/science.1240527"},{"issue":"6","key":"2217_CR59","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4048\/jbc.2020.23.e60","volume":"23","author":"R Jarman","year":"2020","unstructured":"Jarman R, Ribeiro-Milograna S, Kalle W (2020a) Potential of the microbiome as a biomarker for early diagnosis and prognosis of breast cancer. J Breast Cancer 23(6):579","journal-title":"J Breast Cancer"},{"key":"2217_CR60","doi-asserted-by":"crossref","unstructured":"Jarman R, Ribeiro-Milograna S, Kalle W (2020b) Potential of the microbiome as a biomarker for early diagnosis and prognosis of breast cancer. J Breast Cancer, 23(6):579 https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7779729\/","DOI":"10.4048\/jbc.2020.23.e60"},{"key":"2217_CR61","doi-asserted-by":"crossref","unstructured":"Jaye K, Alsherbiny MA, Chang D, Li CG, Bhuyan DJ (2025) Guardians in the gut: mechanistic insights into a hidden ally against triple-negative breast cancer. Cancers (Basel) 17(19):3248. https:\/\/pubmed.ncbi.nlm.nih.gov\/41097775\/","DOI":"10.3390\/cancers17193248"},{"key":"2217_CR62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2021.11.006","volume":"161","author":"Z Juan","year":"2022","unstructured":"Juan Z, Chen J, Ding B, Yongping L, Liu K, Wang L et al (2022) Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial. Eur J Cancer 161:10\u201322. https:\/\/doi.org\/10.1016\/j.ejca.2021.11.006","journal-title":"Eur J Cancer"},{"key":"2217_CR64","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.semcancer.2021.04.020","volume":"86","author":"S Kashyap","year":"2022","unstructured":"Kashyap S, Pal S, Chandan G, Saini V, Chakrabarti S, Saini NK et al (2022) Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers. Semin Cancer Biol 86:643\u2013651","journal-title":"Semin Cancer Biol"},{"key":"2217_CR65","unstructured":"Kwa M, Plottel CS, Blaser MJ, Adams S (2016) The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst. 108(8). https:\/\/pubmed.ncbi.nlm.nih.gov\/27107051\/"},{"issue":"9","key":"2217_CR66","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3390\/cancers12092465","volume":"12","author":"A Laborda-Illanes","year":"2020","unstructured":"Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-M\u00e9ndez I et al (2020) Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers (Basel) 12(9):2465","journal-title":"Cancers (Basel)"},{"key":"2217_CR67","doi-asserted-by":"crossref","unstructured":"Larnder AH, Manges AR, Murphy RA (2025) The estrobolome: estrogen-metabolizing pathways of the gut microbiome and their relation to breast cancer. Int J Cancer, 157(4):599\u2013613. https:\/\/pubmed.ncbi.nlm.nih.gov\/40177842\/","DOI":"10.1002\/ijc.35427"},{"key":"2217_CR68","first-page":"12","volume":"1","author":"Y Li","year":"2022","unstructured":"Li Y, Dong B, Wu W, Wang J, Jin H, Chen K et al (2022) Metagenomic analyses reveal distinct gut microbiota signature for predicting the neoadjuvant chemotherapy responsiveness in breast cancer patients. Front Oncol 1:12","journal-title":"Front Oncol"},{"key":"2217_CR69","doi-asserted-by":"crossref","unstructured":"Li Y, Dong B, Wu W, Wang J, Jin H, Chen K, et al. (2022) Metagenomic analyses reveal distinct gut microbiota signature for predicting the neoadjuvant chemotherapy responsiveness in breast cancer patients. Front Oncol, 12 https:\/\/pubmed.ncbi.nlm.nih.gov\/35433455\/","DOI":"10.3389\/fonc.2022.865121"},{"key":"2217_CR70","doi-asserted-by":"crossref","unstructured":"Luan B, Ge F, Lu X, Li Z, Zhang H, Wu J, et al. (2024) Changes in the fecal microbiota of breast cancer patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis. Clin Transl Oncol, 26(6):1480\u20131496. https:\/\/pubmed.ncbi.nlm.nih.gov\/38217684\/","DOI":"10.1007\/s12094-023-03373-5"},{"key":"2217_CR71","doi-asserted-by":"crossref","unstructured":"\u0141ukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanis\u0142awek A (2021) Breast cancer\u2014epidemiology, risk factors, classification, prognostic markers, and current treatment strategies\u2014an updated review. Cancers (Basel). 13(17):4287. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8428369\/","DOI":"10.3390\/cancers13174287"},{"key":"2217_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fmicb.2019.01050","volume":"10","author":"W Ma","year":"2019","unstructured":"Ma W, Mao Q, Xia W, Dong G, Yu C, Jiang F (2019) Gut microbiota shapes the efficiency of cancer therapy. Front Microbiol 10:25","journal-title":"Front Microbiol"},{"issue":"6","key":"2217_CR73","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/nu14061186","volume":"14","author":"G Maitiniyazi","year":"2022","unstructured":"Maitiniyazi G, Cao X, Chen Y, Zhang R, Liu Y, Li Z et al (2022) Impact of gut microbiota on the association between diet and depressive symptoms in breast cancer. Nutrients 14(6):1186","journal-title":"Nutrients"},{"issue":"1","key":"2217_CR74","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/10942912.2018.1448994","volume":"21","author":"SS Malik","year":"2018","unstructured":"Malik SS, Saeed A, Baig M, Asif N, Masood N, Yasmin A (2018) Anticarcinogenecity of microbiota and probiotics in breast cancer. Int J Food Prop 21(1):655\u2013666. https:\/\/doi.org\/10.1080\/10942912.2018.1448994","journal-title":"Int J Food Prop"},{"key":"2217_CR75","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01237-24","author":"E McCune","year":"2024","unstructured":"McCune E, Sharma A, Johnson B, O\u2019Meara T, Theiner S, Campos M et al (2024) Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma in situ, and healthy women. mSystems. https:\/\/doi.org\/10.1128\/msystems.01237-24","journal-title":"mSystems"},{"issue":"2","key":"2217_CR76","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4081\/oncol.2019.422","volume":"13","author":"L Mendoza","year":"2019","unstructured":"Mendoza L (2019) Potential effect of probiotics in the treatment of breast cancer. Oncol Rev 13(2):422","journal-title":"Oncol Rev"},{"issue":"5_Supplement","key":"2217_CR77","doi-asserted-by":"publisher","first-page":"P2\u201312\u201302-P2\u201312\u2013","DOI":"10.1158\/1538-7445.SABCS22-P2-12-02","volume":"83","author":"CI Moon","year":"2023","unstructured":"Moon CI, Jia B, Zhang B (2023) Abstract P2\u201312\u201302: ClinicalomicsDB - Bridging the gap between clinical omics data and machine learning. Cancer Res 83(5_Supplement):P2-12-02-P2-12\u201302","journal-title":"Cancer Res"},{"key":"2217_CR78","doi-asserted-by":"crossref","unstructured":"Nama ASA, Sandeepa GM, Buddolla V, Mastan A (2025) Advances in understanding therapeutic mechanisms of probiotics in cancer management, with special emphasis on breast cancer: A comprehensive review. Eur J Pharmacol, 995. https:\/\/pubmed.ncbi.nlm.nih.gov\/39986595\/","DOI":"10.1016\/j.ejphar.2025.177410"},{"key":"2217_CR79","doi-asserted-by":"crossref","unstructured":"Nandi D, Parida S, Sharma D (2023) The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful! Gut Microbes, 15(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/37305949\/","DOI":"10.1080\/19490976.2023.2221452"},{"issue":"26","key":"2217_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmic.2025.100155","volume":"1","author":"HA Nazeer","year":"2025","unstructured":"Nazeer HA, Kannan S, Balakrishanan J, Nair VK, Kavitha Y, Bhosale NK (2025) The gut microbiota and breast cancer: A comprehensive review of emerging links and therapeutic implications. Medicine in Microecology 1(26):100155","journal-title":"Medicine in Microecology"},{"issue":"7_Supplement","key":"2217_CR81","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1158\/1538-7445.AM2023-3041","volume":"83","author":"SM Nguyen","year":"2023","unstructured":"Nguyen SM, Tran HT, Long J, Shrubsole MJ, Cai H, Yang Y et al (2023) Abstract 3041: Gut microbiome in association with chemotherapy-induced toxicities among breast cancer patients. Cancer Res 83(7_Supplement):3041\u20133041","journal-title":"Cancer Res"},{"key":"2217_CR82","doi-asserted-by":"crossref","unstructured":"Panebianco C, Latiano T, Pazienza V (2020) Microbiota manipulation by probiotics administration as emerging tool in cancer prevention and therapy. Front Oncol, 10. https:\/\/pubmed.ncbi.nlm.nih.gov\/32523887\/","DOI":"10.3389\/fonc.2020.00679"},{"key":"2217_CR83","doi-asserted-by":"crossref","unstructured":"Parida S, Sharma D (2019) The microbiome-estrogen connection and breast cancer risk. Cells, 8(12). https:\/\/pubmed.ncbi.nlm.nih.gov\/31847455\/","DOI":"10.3390\/cells8121642"},{"issue":"12","key":"2217_CR84","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/cells8121642","volume":"8","author":"S Parida","year":"2019","unstructured":"Parida S, Sharma D (2019) The microbiome-estrogen connection and breast cancer risk. Cells 8(12):1642","journal-title":"Cells"},{"key":"2217_CR85","doi-asserted-by":"crossref","unstructured":"Peddarapu RK, Nunemuntala V, Koora S, Kuntala S, Neeradi J, Annam NS (2023) Breast cancer survival prediction and analysis. In: 2023 International conference on sustainable computing and smart systems (ICSCSS). IEEE. pp. 843\u2013850","DOI":"10.1109\/ICSCSS57650.2023.10169577"},{"issue":"1","key":"2217_CR86","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/ijms21010131","volume":"21","author":"J Qiu","year":"2019","unstructured":"Qiu J, Zhang T, Zhu X, Yang C, Wang Y, Zhou N et al (2019) Hyperoside induces breast cancer cells apoptosis via ROS-mediated NF-\u03baB signaling pathway. Int J Mol Sci 21(1):131","journal-title":"Int J Mol Sci"},{"issue":"16","key":"2217_CR87","doi-asserted-by":"publisher","first-page":"1591745","DOI":"10.3389\/fmicb.2025.1591745","volume":"27","author":"X Ren","year":"2025","unstructured":"Ren X, Zheng L, Huang L, Zhao J (2025) The role of the gut microbiota in shaping the tumor microenvironment and immunotherapy of breast cancer. Front Microbiol 27(16):1591745","journal-title":"Front Microbiol"},{"issue":"222","key":"2217_CR88","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ymeth.2023.12.007","volume":"1","author":"J Roach","year":"2024","unstructured":"Roach J, Mital R, Haffner JJ, Colwell N, Coats R, Palacios HM et al (2024) Microbiome metabolite quantification methods enabling insights into human health and disease. Methods 1(222):81\u201399","journal-title":"Methods"},{"key":"2217_CR89","doi-asserted-by":"crossref","unstructured":"Rosean CB, Bostic RR, Ferey JCM, Feng TY, Azar FN, Tung KS, et al. (2025) Preexisting commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer. Cancer Res, 79(14):3662\u20133675 https:\/\/pubmed.ncbi.nlm.nih.gov\/31064848\/","DOI":"10.1158\/0008-5472.CAN-18-3464"},{"issue":"12_Supplement","key":"2217_CR90","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1158\/1538-7445.AM2022-476","volume":"82","author":"SJ Sammut","year":"2022","unstructured":"Sammut SJ, Crispin-Ortuzar M, Chin SF, Provenzano E, Cope W, Dariush A et al (2022) Abstract 476: Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling. Cancer Res 82(12_Supplement):476\u2013476","journal-title":"Cancer Res"},{"issue":"23","key":"2217_CR91","doi-asserted-by":"publisher","first-page":"9239","DOI":"10.3390\/ijms21239239","volume":"21","author":"K Sampsell","year":"2020","unstructured":"Sampsell K, Hao D, Reimer RA (2020) The gut microbiota: a potential gateway to improved health outcomes in breast cancer treatment and survivorship. Int J Mol Sci 21(23):9239","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2217_CR92","first-page":"3422","volume":"12","author":"A Schoeller","year":"2022","unstructured":"Schoeller A, Karki K, Jayaraman A, Chapkin RS, Safe S (2022) Short chain fatty acids exhibit selective estrogen receptor downregulator (SERD) activity in breast cancer. Am J Cancer Res 12(7):3422","journal-title":"Am J Cancer Res"},{"key":"2217_CR93","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/ijms23010488","volume":"23","author":"A Sevcikova","year":"2022","unstructured":"Sevcikova A, Izoldova N, Stevurkova V, Kasperova B, Chovanec M, Ciernikova S et al (2022) The impact of the microbiome on resistance to cancer treatment with chemotherapeutic agents and immunotherapy. Int J Mol Sci 23:488","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2217_CR94","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/carcin\/bgab060","volume":"42","author":"A Sheikh","year":"2021","unstructured":"Sheikh A, Taube J, Greathouse KL (2021) Contribution of the microbiota and their secretory products to inflammation and colorectal cancer pathogenesis: the role of toll-like receptors. Carcinogenesis 42(9):1133\u20131142","journal-title":"Carcinogenesis"},{"issue":"3","key":"2217_CR95","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/jjco\/hyz213","volume":"50","author":"T Shien","year":"2020","unstructured":"Shien T, Iwata H (2020) Adjuvant and neoadjuvant therapy for breast cancer. Jpn J Clin Oncol 50(3):225\u2013229","journal-title":"Jpn J Clin Oncol"},{"key":"2217_CR96","unstructured":"Study Details, NCT07044310 | 5-strain Probiotic formulation in hr-positive breast cancer receiving aromatase inhibitor to prevent bone loss, ClinicalTrials.gov [Internet]. (2025). https:\/\/clinicaltrials.gov\/study\/NCT07044310"},{"key":"2217_CR97","unstructured":"Study details, NCT04362826, Study to investigate efficacy of a novel probiotic on the bacteriome and mycobiome of breast cancer, (2025) ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT04362826"},{"issue":"10","key":"2217_CR98","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41396-023-01483-0","volume":"17","author":"J Sun","year":"2023","unstructured":"Sun J, Chen F, Wu G (2023) Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy. ISME J 17(10):1535\u20131551","journal-title":"ISME J"},{"issue":"9","key":"2217_CR99","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41418-021-00784-1","volume":"28","author":"S Terrisse","year":"2021","unstructured":"Terrisse S, Derosa L, Iebba V, Ghiringhelli F, Vaz-Luis I, Kroemer G et al (2021) Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment. Cell Death Differ 28(9):2778\u20132796","journal-title":"Cell Death Differ"},{"issue":"3","key":"2217_CR100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.15698\/cst2023.03.277","volume":"7","author":"S Terrisse","year":"2023","unstructured":"Terrisse S, Zitvogel L, Kroemer G (2023) Impact of microbiota on breast cancer hormone therapy. Cell Stress 7(3):12","journal-title":"Cell Stress"},{"issue":"5","key":"2217_CR101","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3390\/ijms25052668","volume":"25","author":"R Teschke","year":"2024","unstructured":"Teschke R (2024) Hemochromatosis: ferroptosis, ROS, gut microbiome, and clinical challenges with alcohol as confounding variable. Int J Mol Sci 25(5):2668","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2217_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188873","volume":"12","author":"KJ Thompson","year":"2017","unstructured":"Thompson KJ, Ingle JN, Tang X, Chia N, Jeraldo PR, Walther-Antonio MR et al (2017) A comprehensive analysis of breast cancer microbiota and host gene expression. PLoS ONE 12(11):e0188873","journal-title":"PLoS ONE"},{"key":"2217_CR103","first-page":"13","volume":"17","author":"MS Thu","year":"2023","unstructured":"Thu MS, Chotirosniramit K, Nopsopon T, Hirankarn N, Pongpirul K (2023) Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis. Front Oncol 17:13","journal-title":"Front Oncol"},{"key":"2217_CR104","doi-asserted-by":"crossref","unstructured":"Toumazi D, El Daccache S, Constantinou C (2021) An unexpected link: the role of mammary and gut microbiota on breast cancer development and management (Review). Oncol Rep, 45(5). https:\/\/pubmed.ncbi.nlm.nih.gov\/33786630\/","DOI":"10.3892\/or.2021.8031"},{"issue":"1","key":"2217_CR105","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-021-00874-2","volume":"13","author":"A Tzeng","year":"2021","unstructured":"Tzeng A, Sangwan N, Jia M, Liu CC, Keslar KS, Downs-Kelly E et al (2021) Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer. Genome Med. 13(1):60","journal-title":"Genome Med."},{"key":"2217_CR106","doi-asserted-by":"crossref","unstructured":"Ullern A, Holm K, R\u00f8ssevold AH, Andresen NK, Bang C, Lingj\u00e6rde OC, et al. (2025) Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer. Mol Oncol, 19(4):1229\u20131243 https:\/\/pubmed.ncbi.nlm.nih.gov\/39545921\/","DOI":"10.1002\/1878-0261.13760"},{"key":"2217_CR107","doi-asserted-by":"crossref","unstructured":"Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH (2004) Antibiotic use in relation to the risk of breast cancer. JAMA, 291(7):827\u2013835 https:\/\/pubmed.ncbi.nlm.nih.gov\/14970061\/","DOI":"10.1001\/jama.291.7.827"},{"issue":"3","key":"2217_CR108","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/pathogens12030468","volume":"12","author":"S Viswanathan","year":"2023","unstructured":"Viswanathan S, Parida S, Lingipilli BT, Krishnan R, Podipireddy DR, Muniraj N (2023) Role of gut microbiota in breast cancer and drug resistance. Pathogens 12(3):468","journal-title":"Pathogens"},{"key":"2217_CR109","doi-asserted-by":"publisher","first-page":"815772","DOI":"10.3389\/fonc.2021.815772","volume":"11","author":"M Vitorino","year":"2022","unstructured":"Vitorino M, Baptista de Almeida S, Alpuim Costa D, Faria A, Calhau C, Azambuja Braga S (2022) Human microbiota and immunotherapy in breast cancer - a review of recent developments. Front Oncol 11:815772","journal-title":"Front Oncol"},{"key":"2217_CR110","first-page":"12","volume":"13","author":"N Wang","year":"2022","unstructured":"Wang N, Yang J, Han W, Han M, Liu X, Jiang L et al (2022) Identifying distinctive tissue and fecal microbial signatures and the tumor-promoting effects of deoxycholic acid on breast cancer. Front Cell Infect Microbiol 13:12","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2217_CR111","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13059-021-02306-1","volume":"22","author":"J Wirbel","year":"2021","unstructured":"Wirbel J, Zych K, Essex M, Karcher N, Kartal E, Salazar G et al (2021) Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol 22(1):93","journal-title":"Genome Biol"},{"key":"2217_CR112","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2019.03.010","volume":"452","author":"X Wu","year":"2019","unstructured":"Wu X, Zhang T, Chen X, Ji G, Zhang F (2019) Microbiota transplantation: targeting cancer treatment. Cancer Lett 452:144\u2013151","journal-title":"Cancer Lett"},{"issue":"2","key":"2217_CR113","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10549-020-05702-6","volume":"182","author":"AH Wu","year":"2020","unstructured":"Wu AH, Tseng C, Vigen C, Yu Y, Cozen W, Garcia AA et al (2020) Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study. Breast Cancer Res Treat 182(2):451\u2013463","journal-title":"Breast Cancer Res Treat"},{"key":"2217_CR114","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/BCTT.S305486","volume":"14","author":"AH Wu","year":"2022","unstructured":"Wu AH, Vigen C, Tseng C, Garcia AA, Spicer D (2022) Effect of chemotherapy on the gut microbiome of breast cancer patients during the first year of treatment. Breast Cancer Targets Ther 14:433\u2013451","journal-title":"Breast Cancer Targets Ther"},{"key":"2217_CR115","doi-asserted-by":"crossref","unstructured":"Xu HM, Huang HL, Zhou YL, Zhao HL, Xu J, Shou DW, et al. (2021) Fecal microbiota transplantation: a new therapeutic attempt from the gut to the brain. Gastroenterol Res Pract, https:\/\/pubmed.ncbi.nlm.nih.gov\/33510784\/","DOI":"10.1155\/2021\/6699268"},{"issue":"1","key":"2217_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083744","volume":"9","author":"C Xuan","year":"2014","unstructured":"Xuan C, Shamonki JM, Chung A, DiNome ML, Chung M, Sieling PA et al (2014) Microbial dysbiosis is associated with human breast cancer. PLoS ONE 9(1):e83744","journal-title":"PLoS ONE"},{"issue":"7","key":"2217_CR117","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3390\/pharmaceutics15071827","volume":"15","author":"P Yao","year":"2023","unstructured":"Yao P, Wang X, Wang Q, Dai Q, Peng Y, Yuan Q et al (2023) Cyclic RGD-functionalized pH\/ROS dual-responsive nanoparticle for targeted breast cancer therapy. Pharmaceutics 15(7):1827","journal-title":"Pharmaceutics"},{"key":"2217_CR118","doi-asserted-by":"crossref","unstructured":"Zhou Y, Jiang M, Shen K, He T, Zhou S, Shao A, et al. (2025) Optimizing breast cancer chemotherapy by harnessing gut microbiota with insights from artificial intelligence. NPJ Biofilms Microb, 11(1):1\u201321. https:\/\/www.nature.com\/articles\/s41522-025-00825-4","DOI":"10.1038\/s41522-025-00825-4"},{"key":"2217_CR119","first-page":"10","volume":"22","author":"Q Zhu","year":"2019","unstructured":"Zhu Q, Jiang X, Zhu Q, Pan M, He T (2019) Graph embedding deep learning guides microbial biomarkers\u2019 identification. Front Genet 22:10","journal-title":"Front Genet"}],"container-title":["Antonie van Leeuwenhoek"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02217-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10482-025-02217-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02217-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:28:06Z","timestamp":1768472886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10482-025-02217-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2217"],"URL":"https:\/\/doi.org\/10.1007\/s10482-025-02217-2","relation":{},"ISSN":["0003-6072","1572-9699"],"issn-type":[{"value":"0003-6072","type":"print"},{"value":"1572-9699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The grant number reported in the Funding section has been updated to 1403-41766.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors consented to their participation in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors consent to the publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"14"}}